NewsBenzingaTDコーウェン、バイオジェンの「買い」を維持、目標株価を260ドルに引き上げ TDコーウェン、バイオジェンの「買い」を維持、目標株価を260ドルに引き上げ Benzinga 2026.10.29 16:07 (GMT+0) Open on Benzinga Other news A Starbucks turnaround is brewing — but perhaps not quickly enough Micron: The 5x P/E Isn't As Cheap As It Looks, But The Upside Remains (NASDAQ:MU) IDACORP, Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:IDA) 2026-10-29 First Solar, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:FSLR) 2026-10-29 GM reaches $220M settlement over selling drivers’ private data Industrial Logistics Properties Trust (ILPT) Q3 2026 Earnings Call Transcript
